Physician profile
John Eric Owens
NPI 1851502314
$646.13
in general payments reported to CMS, 2019-2025
9 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $46.72 · 2023: $16.32 · 2024: $93.76 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $243.42 | 2020-2025 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $138.62 | 2024-2025 | |
| Pacira Therapeutics, INC. | $125.41 | 2019-2020 | |
| Smith+Nephew, INC. | $39.39 | 2019-2025 | Pico 14 |
| Convatec INC. | $32.79 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $20.27 | 2025 | Iovera, Zilretta |
| Davol INC. | $17.36 | 2024 | |
| Ibsa Pharma INC. | $16.32 | 2023 | Tirosint, Licart |
| Cumberland Pharmaceuticals, INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.